1. Renoprotective effect of isoliquiritigenin on cisplatin-induced acute kidney injury through inhibition of FPR2 in macrophage
- Author
-
Liao Yuan, Tan Rui-zhi, Zhu Bing-wen, Xie Ke-huan, Wang Li, Lin Xiao, and Liu Tong-tong
- Subjects
Male ,FPR2 ,Gene Expression ,Inflammation ,RM1-950 ,urologic and male genital diseases ,Mcarophage ,chemistry.chemical_compound ,Chalcones ,AKI ,Downregulation and upregulation ,Glycyrrhiza ,medicine ,Animals ,Macrophage ,Molecular Targeted Therapy ,Receptors, Lipoxin ,Receptor ,Cells, Cultured ,Pharmacology ,Cisplatin ,urogenital system ,business.industry ,Macrophages ,Acute kidney injury ,Transfection ,Acute Kidney Injury ,medicine.disease ,Receptors, Formyl Peptide ,female genital diseases and pregnancy complications ,Up-Regulation ,Mice, Inbred C57BL ,chemistry ,Cancer research ,Molecular Medicine ,Therapeutics. Pharmacology ,medicine.symptom ,business ,Isoliquiritigenin ,Phytotherapy ,Isoliquirigenin ,medicine.drug - Abstract
Acute kidney injury (AKI) is a serious complication in critically ill patients. Accumulating evidences indicated that macrophages play an important pro-inflammatory role in AKI and isoliquiritigenin (ISL) can inhibit macrophagic inflammation, but its role in AKI and the underlying mechanism are unknown. The present study aims to investigate the renoprotective effect of ISL on AKI and the role of Formyl peptide receptors 2 (FPR2) in this process. In this study, cisplatin-induced AKI model and lipopolysaccharide-induced macrophage inflammatory model were employed to perform the in vivo and in vitro experiments. The results showed that ISL strongly relieved kidney injury and inhibited renal inflammation in vivo and suppress macrophagic inflammatory response in vitro. Importantly, it was found that FPR2 was significantly upregulated compared to the control group in AKI and LPS-induced macrophage, whereas it was strongly suppressed by ISL. Interestingly, overexpression of FPR2 with transfection of pcDNA3.1-FPR2 effectively reversed the anti-inflammatory effect of ISL in macrophage, suggesting that FPR2 may be the potential target for ISL to prevent inflammation and improve kidney injury of AKI. Take together, these findings indicated that ISL improved cisplantin-induced kidney injury by inhibiting FPR2 involved macrophagic inflammation, which may provide a potential therapeutic option for AKI.
- Published
- 2022
- Full Text
- View/download PDF